Functional significance of IL-1B in breast cancer bone metastases
Dr P Ottewell
Applications accepted all year round
Breast cancer is the most frequently diagnosed cancer and leading cause of death in women worldwide. Up to 75% of patients with advanced breast cancer develop bone metastases and patients with this condition have a median survival of around 2-3 years.
Precision profiling the breast cancer microenvironment
Prof V Speirs, Dr R Abu Eid
29 March 2019
The cancer microenvironment contains many different cell types, including various subsets of immune cells and cancer-associated fibroblasts, which support cancer growth.